Bookmark

Add to MyYahoo RSS

Johnson & Johnson News

News on Johnson & Johnson continually updated from thousands of sources around the net.

1 hr ago | Forbes.com

One Put, One Call Option To Know About for Johnson & Johnson

Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson .

Comment?

Related Topix: Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Sun Jul 27, 2014

The Telegraph

High valuations put on older generics

Mumbai, July 27: GlaxoSmithKline Plc is likely to receive a good response if it indeed puts up its older but off-patented drugs for sale, given the massive gain Bafna Pharma made from Raricap.

Comment?

Related Topix: Biotech, Dr Reddys Laboratories, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups

Fri Jul 25, 2014

Reuters

Europe backs new leukaemia drugs from J&J and Gilead

Two new leukaemia drugs from Johnson & Johnson and Gilead Sciences have been recommended for approval by European regulators, paving the way for formal approval in a couple of months.

Comment?

Related Topix: Biotech, Medicine, Gilead Sciences, Healthcare Industry, Food, J and J Snack Foods, Johnson and Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals

Thu Jul 24, 2014

Heavy Duty Trucking

Baxter Healthcare's Fleet Manager Receives 2014 Fleet Safety Award

Fleet Safety Conference Chair Mike Antich, 2014 Fleet Safety Award Honoree Kristin O'Driscoll of Baxter Healthcare, and Pam Sederholm, executive director or AALA.

Comment?

Related Topix: Schaumburg, IL, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Truckers

GigaOM

Johnson & Johnson partners with Organovo to consider 3D-printing living tissue

The partnership centers around using bioprinted tissue to discover new drugs. The announcement comes ahead of Organovo's commercial launch later this year.

Comment?

Related Topix: Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

CNN

Xarelto Lawsuits Start To Be Filed In The US Due To "Irreversible Bleeds"

Germany-based Bayer AG is facing its first lawsuits in the United States over Xarelto, which is among the company's top-selling medications.

Comment?

Related Topix: e-Spirit, Bayer AG, Manufacturing, Biotech, Pharmaceuticals, Chemicals, Johnson and Johnson, Medicine, Healthcare Industry

Customer Interaction Solutions

Johnson & Johnson Announces $5 Billion Share Repurchase Program

ENP Newswire - 24 July 2014 Release date- 23072014 - New Brunswick, NJ - Johnson & Johnson today announced that its Board of Directors has approved the repurchase of up to $5 billion of the company's common stock.

Comment?

Related Topix: Biotech, Johnson and Johnson, Medicine, Healthcare Industry, Aria Systems, New Brunswick, NJ

The New Zealand Herald

What's best for baby?

Sharon Dowling, research and development manager for leading company Johnson & Johnson , shares her advice.

Comment?

Related Topix: Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Startups, Acclarent, DePuy Orthopaedics, Medical Equipment, Hospital Administration, St Peters Health Care Services

Wed Jul 23, 2014

The Motley Fool

Why the Market Is Wrong About Intuitive Surgical Stock

Strong shipments of the Xi system are encouraging, as was the better-than-expected procedure growth, but utilization is still challenging and Revenue fell more than 11% this quarter, but was still about 2% better than the sell-side expected.

Comment?

Related Topix: Startups, Intuitive Surgical, Science / Technology, Robots, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

Mother Jones

For Lower Back Pain, You Can Skip the Tylenol

About two-thirds of adults have lower back pain at some point in their lives, and most are told to take acetaminophen, sold under brand names like Tylenol, Anacin and Panadol.

Comment?

Related Topix: Tylenol, Tempra, Acetaminophen (generic), Medicine, Health, Pain, Back Pain, Biotech, Johnson and Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

The Washington Post

Puma Biotech Soars on Positive Breast Cancer Drug Results

Puma Biotechnology Inc. soared after the company yesterday reported positive trial results for its breast cancer drug, positioning the company as a potential takeover target.

Comment?

Related Topix: Medicine, Cancer, Health, Breast Cancer, Biotech, Science / Technology, Healthcare Law, Law, Business News

TheStreet.com

Puma Shares Soar When Wall Street Misplays Expectation Game

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Mozilla, Medicine, Health, Breast Cancer, Biotech, Science / Technology, Johnson and Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

TheStreet.com

Puma Shares Soar When Wall Street Misplays Expectation Game

Puma's experimental drug neratinib delayed the return of cancer in a large trial of women with early-stage breast cancer .

Comment?

Related Topix: Medicine, Health, Breast Cancer, Biotech, Science / Technology, Johnson and Johnson, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Business News

Tue Jul 22, 2014

The Motley Fool

3 Quotes From Johnson & Johnson's Conference Call You Need to Read

Here are three quotes from the call and some commentary about why they're so important.

Comment?

Related Topix: Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, OrthoClinical Diagnostics, Medical Equipment, DePuy Orthopaedics, Hospital Administration, St Peters Health Care Services

Business Journal

Johnson & Johnson board approved $5B stock buyback plan

Johnson & Johnson's board of directors approved a plan for the New Jersey health-care company to repurchase up to $5 billion of its common stock.

Comment?

Related Topix: Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

The Jersey Journal

Johnson & Johnson volunteers support Buck Garden in Far Hills

Johnson & Johnson 'Day of Caring' volunteers descended upon Somerset County Park Commission Leonard J. Buck Garden at 11 Layton Road in Far Hills.

Comment?

Related Topix: Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Advanced Transit Dynamics, VisionCare Ophthalmic Technologies, Far Hills, NJ, Startups

The Hartford Courant

Kevin Hunt: Are These Chemicals In Your Deodorant, Shampoo, Soap Or Cosmetics?

Why do so many people care so much about what they put in their body and so little about what they put on it? Europe's regulatory system bans close to 1,400 ingredients in cosmetic products, including carcinogens like parabens and toxic chemicals that can cause reproductive and developmental-health risks.

Comment?

Related Topix: Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, U.S. Environmental Protection Agency, Healthcare Law, Law

DNA India

Strides Arcolab acquires majority stake in Bafna Pharma

Bangalore-based Strides Arcolab, on Monday, said it has entered into an agreement with Chennai-based Bafna Pharmaceuticals to acquire majority stake of its branded generic business for a cash consideration of Rs 48.1 crore.

Comment?

Related Topix: Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry

Mon Jul 21, 2014

Courier News

Heartbeats: Public campaign underway for Saint Peter'sHeartbeats:...

Heartbeats: Public campaign underway for Saint Peter's Health news from New Brunswick, Bernards, Branchburg, Woodbridge, Central Jersey Check out this story on mycentraljersey.com: http://mycj.co/1mydYkp The new and expanded Pediatric Emergency Department at Saint Peter's University Hospital in New Brunswick was completed in the spring of 2013 and ... (more)

Comment?

Related Topix: Medicine, Saint Peter's University Hospital, Hospital Administration, Healthcare Industry, New Brunswick, NJ, Women's Health, Health, Food, J and J Snack Foods

Forbes.com

Daily Dividend Report: JNJ, HAL, AGN, APD, SPN, ZION, BRO

Johnson & Johnson has declared a cash dividend for the third quarter of 2014 of $0.70 per share on the company's common stock.

Comment?

Related Topix: Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Scios, OrthoClinical Diagnostics, Medical Equipment

•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••